Reduce glycemic variability and HbA1c levels
using continuous glucose monitoring vs. fingersticks alone
The revolutionary Guardian® RT system gives patients the benefits of continuous glucose monitoring in
More meaningful insights than fingersticks alone
Reduces HbA1cs and related complications
• Reduces |
therapy adjustment leading to reductions in HbA1c levels versus the use of fingersticks |
Fingersticks taken 4 times only give you part of the picture*
Fingersticks alone
16.7
mmol/L- | 11.1 |
|
|
|
| ||
|
|
| |
Glucose | 5.6 |
|
|
| Target zone | ||
| |||
0 |
|
| |
|
|
| |
|
|
|
• Measures glucose levels continuously: Just as the systems of a human |
body monitors glucose levels to guide insulin release, continuous |
glucose monitoring measures glucose 24 hours a day giving patients |
meaningful insights to help guide therapy decisions |
• HbA1c testing and fingersticks alone provide less meaningful insights |
because they do not monitor glucose levels continuously |
— HbA1c testing is performed at a single point in time, once every |
2 to 3 months and produces an average blood glucose level |
— Fingersticks also measure glucose levels at a single point in time — |
patients test on average 4 to 5 times per day |
— Each 1% reduction in HbA1c reduces the risk of |
disease by 15% to 30%7,12 |
| Continuous glucose monitoring |
duration of hypoglycemic excursions10 | reduces HbA1cs |
3:00 AM 6:00 AM 9:00 AM 12:00 PM 3:00 PM 6:00 PM 9:00 PM |
Time of day |
Continuous glucose monitoring
completes the picture
Continuous glucose monitoring
16.7
Highs missed by these fingersticks
- mmol/L | 11.1 |
|
|
Glucose | 5.6 |
|
|
| Target zone | ||
|
| ||
| 0 |
| Lows missed by these fingersticks |
|
|
3:00 AM 6:00 AM 9:00 AM 12:00 PM 3:00 PM 6:00 PM 9:00 PM
Time of day
• |
readings every five minutes — up to 288 glucose measurements per |
day — to alert patients to take action |
Better detects hypoglycemia and hyperglycemia for more proactive patient
•Identifies hidden variability: Continuous glucose monitoring helps reveal dangerous glucose variability that may not be tracked by fingersticks alone and HbA1c testing6
—60% of lows may not be revealed when using fingersticks alone.9,11 HbA1c testing provides a 2 to 3 month average of glucose levels and isn’t intended to track highs and lows6
—Continuous glucose monitoring identifies up to 4 times more glucose excursions requiring therapy adjustment versus fingersticks alone, so patients can intervene more quickly3
P = 0.03 |
Patient response to
Continuous glucose monitoring vs. fingersticks4
| 9.0 |
|
|
| 8.5 |
| Fingersticks alone |
|
| CGM | |
|
|
| |
% ± SE | 8.0 |
|
|
7.5 |
|
| |
HbA1c, |
|
| |
7.0 |
|
| |
| P = n.s. | P = .011 | |
|
| ||
| 6.5 |
|
|
| 6.0 |
|
|
| Start | 6 weeks | 12 weeks |
glucose monitoring helps to reduce the risk of long- term complications and increase a patient’s lifespan7
* Chart is illustrative of a patient taking 4 fingersticks in one day, at times shown.